Companies Dominating the Antibacterial Haemostatic Gels Market
- Pfizer Inc.
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- DEXX Laboratories Inc.
- Medura
- StopBleed
- Zoetis Inc
- Rapid-Seal
- Coloplast Group
- Gel-e-life sciences
- PREVESTDenPro
- Bio-Chem LLC
- Smith & Nephew
- Medtronic
- B. Braun SE
- 3M Company
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of antibacterial haemostatic gels is evaluated at USD 1.57 billion.
The antibacterial haemostatic gels market size was valued at USD 1.49 billion in 2024 and is set to exceed USD 3.3 billion by 2037, expanding at over 6.3% CAGR during the forecast period i.e., between 2025-2037. The increase in surgical techniques across the world will drive the market growth.
North America industry is predicted to dominate majority revenue share of 43% by 2037, owing to rising advancement of healthcare infrastructure in this region.
The major players in the market are Pfizer Inc., DEXX Laboratories Inc., Medura, StopBleed, Zoetis Inc., Rapid-Seal, Coloplast Group, Gel-e-life sciences, PREVESTDenPro, Bio-Chem LLC, Smith & Nephew, Medtronic, B. Braun SE, 3M.
